Your cart
Your cart is empty.Wellness Resources News
Science-based natural health news to help you take charge of your health!
Our mission & writing commitmentMarch 11, 2024
Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic FaBackground: Berberine is a plant alkaloid that has multiple beneficial effects against intestine inflammation. In our previous study, we have found that [...]
March 11, 2024
Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathwaysBackground: Berberine is known to improve glucose and lipid metabolism disorders, but it poorly absorbed into the blood stream from the gut. Therefore, [...]
March 11, 2024
Glucagon-like peptide-1: modulator of β-cell dysfunction and death.Glucagon-like peptide-1 (GLP-1) is one of the hormones responsible for the incretin effect, a term that refers to the observation that orally administered [...]
March 11, 2024
Glucagon-like peptide 1 (GLP-1).The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the [...]
March 11, 2024
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse EvBackground: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used diabetes and obesity medications but have been associated with [...]
March 11, 2024
Gastrointestinal adverse events associated with semaglutide: A pharmacovigilanceSemaglutide was approved for treatment of type 2 diabetes mellitus (T2DM) and chronic weight management in obesity or overweight adults. However, [...]
March 11, 2024
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of [...]
March 11, 2024
Glucagon-like peptide 1 (GLP-1The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the [...]
March 11, 2024
Off-label antiobesity treatment in patients without diabetes with GLP-1 agonistsThe aim of the work was to investigate whether continuation of treatment, side effects, and effect on weight loss of GLP-1 agonists in obese patients [...]
